SBP solbec pharmaceuticals limited

torisel in rcc. , page-3

  1. 5,995 Posts.
    lightbulb Created with Sketch. 162
    Thanks Componed, with Biotech you need to keep an eye on what competing treatments are emerging. To date I have seen nothing to compare with what has been seen so far on RCC.
    Of course not everything would compete. Look at Biomedicas Trovax for instance. Has just been taken on by a big partner after seeing some good results against RCC. Coramsine's ability to kill cancer cells by necrosis while leaving the immune systen intact, even as reported in preclinicals, strengthening the immune response, may make the therapeutic vaccines in developement so much more powerful.
    http://www.oxfordbiomedica.co.uk/trovax.htm
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.